LXRX - Lexicon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LXRX is currently covered by 2 analysts with an average price target of $3.79. This is a potential upside of $2.46 (184.96%) from yesterday's end of day stock price of $1.33.

Lexicon Pharmaceuticals's activity chart (see below) currently has 51 price targets and 55 ratings on display. The stock rating distribution of LXRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.5% with an average time for these price targets to be met of 66 days.

Highest price target for LXRX is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 01-Sep-2025. First documented stock forecast 11-Oct-2013.

Currently out of the existing stock ratings of LXRX, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$4

$2.58 (181.69%)

1 months 28 days ago
(01-Sep-2025)

0/6 (0%)

$2.88 (257.14%)

Buy

$10

7 months 23 days ago
(06-Mar-2025)

0/2 (0%)

$7.55 (308.16%)

Buy

$4

$2.58 (181.69%)

$8

1 years 10 months 18 days ago
(11-Dec-2023)

4/15 (26.67%)

$2.82 (238.98%)

47

Buy

$2

$0.58 (40.85%)

4 years 9 months 1 days ago
(28-Jan-2021)

2/6 (33.33%)

$-5.91 (-74.72%)

409

Sell

4 years 9 months 1 days ago
(28-Jan-2021)

2/2 (100%)

$1.91 (23.61%)

65

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LXRX (Lexicon Pharmaceuticals) average time for price targets to be met?

On average it took 66 days on average for the stock forecasts to be realized with a an average price target met ratio 32.5

Which analyst has the current highest performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

JESSICA FYE

Which analyst has the current lower performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on LXRX (Lexicon Pharmaceuticals)?

Jessica Fye works at JPMORGAN and has 2 price targets and 5 ratings on LXRX

Which analyst is the currently most bullish on LXRX (Lexicon Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $2.58

Which analyst is the currently most reserved on LXRX (Lexicon Pharmaceuticals)?

Stephen Willey with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?